CompletedPhase 3NCT00000173

Memory Impairment Study (Mild Cognitive Impairment Study)

Studying Early-onset autosomal dominant Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute on Aging (NIA)
Principal Investigator
Leon Thal, MD
Alzheimer's Disease Cooperative Study
Intervention
Donepezil(drug)
Eligibility
55-90 years · All sexes
Timeline
19992004

Study locations (30)

Collaborators

Alzheimer's Disease Cooperative Study (ADCS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00000173 on ClinicalTrials.gov

Other trials for Early-onset autosomal dominant Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for Early-onset autosomal dominant Alzheimer disease

← Back to all trials